The Assessment and Treatment of Addiction

Dr. Danovitch is the Chairman of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. He earned his bachelor's degree from UC Berkeley, and his medical doctorate from UCLA. He completed psychiatry residency at Columbia, an addiction psychiatry fellowship at Cedars-Sinai Medical Center, and a Master of Business Administration at the UCLA Anderson School of Management. Dr. Danovitch's research is focused on substance use disorders, particularly marijuana, as well as the integration of medical and mental health services. He is the author of over 50 original articles and book chapters. He was co-editor of the 2012 Psychiatric Clinics of North America special edition on addiction. As an educator, Dr. Danovitch has been recognized with the Golden Apple Award for Excellence in Teaching. Dr. Danovitch is a Distinguished Fellow of the American Society of Addiction Medicine, a Fellow of the American Psychiatric Association, and Past President of the California Society of Addiction Medicine. In 2016 he was appointed by Governor Jerry Brown to serve as a Commissioner on the California Mental Health Services Oversight and Accountability Commission. Dr. Larissa Mooney is a board certified addiction psychiatrist and Associate Clinical Professor of Psychiatry at the University of California, Los Angeles (UCLA). She completed psychiatry residency at New York University and a fellowship in addiction psychiatry at Cedars-Sinai Medical Center. Dr. Mooney is the Director of the UCLA Addiction Medicine Clinic and Chief of the Greater Los Angeles Veterans Affairs Substance Use Disorders Section, where she teaches psychiatrists in training in the clinical management of addiction and mental health disorders. She is the Vice President of the American Academy of Addiction Psychiatry (AAAP) and a Fellow of the American Psychiatric Association. Dr. Mooney has conducted research at UCLA Integrated Substance Abuse Programs on pharmacological and behavioral treatment interventions for substance use disorders and has current funding from the National Institute on Drug Abuse (NIDA) to study treatment outcomes related to cannabis use disorder and medication treatment for opioid use disorder.